Annual CAPEX:
$3.81B+$1.06B(+38.46%)Summary
- As of today, NVS annual capital expenditures is $3.81 billion, with the most recent change of +$1.06 billion (+38.46%) on December 31, 2024.
- During the last 3 years, NVS annual CAPEX has risen by +$779.84 million (+25.72%).
- NVS annual CAPEX is now -27.71% below its all-time high of $5.27 billion, reached on December 31, 2001.
Performance
NVS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$829.52M+$250.53M(+43.27%)Summary
- As of today, NVS quarterly capital expenditures is $829.52 million, with the most recent change of +$250.53 million (+43.27%) on September 29, 2025.
- Over the past year, NVS quarterly CAPEX has increased by +$30.52 million (+3.82%).
- NVS quarterly CAPEX is now -56.13% below its all-time high of $1.89 billion, reached on December 31, 2015.
Performance
NVS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$4.03B+$30.52M(+0.76%)Summary
- As of today, NVS TTM capital expenditures is $4.03 billion, with the most recent change of +$30.52 million (+0.76%) on September 29, 2025.
- Over the past year, NVS TTM CAPEX has increased by +$567.51 million (+16.37%).
- NVS TTM CAPEX is now -5.18% below its all-time high of $4.25 billion, reached on September 30, 2016.
Performance
NVS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +38.5% | +3.8% | +16.4% |
| 3Y3 Years | +25.7% | +176.5% | +48.1% |
| 5Y5 Years | +64.5% | +31.1% | +77.1% |
NVS CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +70.2% | -44.5% | +176.5% | -2.9% | +127.2% |
| 5Y | 5-Year | at high | +70.2% | -44.5% | +176.5% | -2.9% | +127.2% |
| All-Time | All-Time | -27.7% | +229.4% | -56.1% | +320.0% | -5.2% | +1391.1% |
NVS CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $829.52M(+43.3%) | $4.03B(+0.8%) |
| Jun 2025 | - | $578.99M(-61.2%) | $4.00B(-3.6%) |
| Mar 2025 | - | $1.49B(+32.1%) | $4.15B(+8.9%) |
| Dec 2024 | $3.81B(+38.5%) | $1.13B(+41.6%) | $3.81B(+10.0%) |
| Sep 2024 | - | $799.00M(+9.8%) | $3.47B(+3.5%) |
| Jun 2024 | - | $728.00M(-37.0%) | $3.35B(-4.8%) |
| Mar 2024 | - | $1.16B(+47.6%) | $3.52B(+27.8%) |
| Dec 2023 | $2.75B(+22.9%) | $783.00M(+14.6%) | $2.75B(+11.3%) |
| Sep 2023 | - | $683.00M(-24.0%) | $2.47B(+18.3%) |
| Jun 2023 | - | $898.40M(+130.4%) | $2.09B(+17.8%) |
| Mar 2023 | - | $389.91M(-22.4%) | $1.78B(-20.9%) |
| Dec 2022 | $2.24B(-26.1%) | $502.37M(+67.5%) | $2.24B(-17.6%) |
| Sep 2022 | - | $300.00M(-48.5%) | $2.72B(-8.5%) |
| Jun 2022 | - | $583.00M(-32.1%) | $2.98B(-1.5%) |
| Mar 2022 | - | $859.00M(-12.5%) | $3.02B(-0.4%) |
| Dec 2021 | $3.03B(+14.6%) | $982.00M(+77.6%) | $3.03B(-1.6%) |
| Sep 2021 | - | $553.00M(-11.8%) | $3.08B(-2.5%) |
| Jun 2021 | - | $627.00M(-27.9%) | $3.16B(+5.6%) |
| Mar 2021 | - | $870.00M(-15.5%) | $2.99B(+13.1%) |
| Dec 2020 | $2.65B(+14.2%) | $1.03B(+62.7%) | $2.65B(+16.2%) |
| Sep 2020 | - | $633.00M(+37.9%) | $2.28B(+2.8%) |
| Jun 2020 | - | $459.00M(-12.4%) | $2.22B(+0.2%) |
| Mar 2020 | - | $524.00M(-20.8%) | $2.21B(-4.5%) |
| Dec 2019 | $2.32B(-13.8%) | $662.00M(+15.7%) | $2.32B(-0.3%) |
| Sep 2019 | - | $572.00M(+26.0%) | $2.32B(-10.8%) |
| Jun 2019 | - | $454.00M(-27.8%) | $2.61B(-1.4%) |
| Mar 2019 | - | $629.00M(-6.0%) | $2.64B(-1.8%) |
| Dec 2018 | $2.69B(-2.1%) | $669.15M(-21.6%) | $2.69B(-10.0%) |
| Sep 2018 | - | $854.00M(+73.6%) | $2.99B(+15.6%) |
| Jun 2018 | - | $492.00M(-27.4%) | $2.59B(-3.8%) |
| Mar 2018 | - | $678.00M(-30.1%) | $2.69B(-2.0%) |
| Dec 2017 | $2.75B(-4.6%) | $970.00M(+116.0%) | $2.75B(+19.8%) |
| Sep 2017 | - | $449.00M(-24.4%) | $2.29B(-32.0%) |
| Jun 2017 | - | $594.00M(-19.0%) | $3.37B(+4.5%) |
| Mar 2017 | - | $733.00M(+42.1%) | $3.23B(+12.1%) |
| Dec 2016 | $2.88B(-17.9%) | $516.00M(-66.3%) | $2.88B(-32.3%) |
| Sep 2016 | - | $1.53B(+241.5%) | $4.25B(+28.8%) |
| Jun 2016 | - | $448.00M(+16.4%) | $3.30B(-3.4%) |
| Mar 2016 | - | $385.00M(-79.6%) | $3.42B(-2.4%) |
| Dec 2015 | $3.50B(+3.0%) | $1.89B(+226.6%) | $3.50B(+8.7%) |
| Sep 2015 | - | $579.00M(+2.3%) | $3.22B(+13.4%) |
| Jun 2015 | - | $566.00M(+20.7%) | $2.84B(-11.1%) |
| Mar 2015 | - | $469.00M(-70.9%) | $3.20B(-6.1%) |
| Dec 2014 | $3.40B(+0.8%) | $1.61B(+715.2%) | $3.40B(+2.6%) |
| Sep 2014 | - | $197.50M(-78.5%) | $3.32B(-6.6%) |
| Jun 2014 | - | $920.53M(+36.2%) | $3.55B(-0.1%) |
| Mar 2014 | - | $675.96M(-55.6%) | $3.55B(+5.2%) |
| Dec 2013 | $3.38B | $1.52B(+252.5%) | $3.38B(+18.2%) |
| Sep 2013 | - | $432.00M(-53.2%) | $2.86B(-10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | $923.49M(+84.9%) | $3.20B(+0.8%) |
| Mar 2013 | - | $499.51M(-50.2%) | $3.18B(+3.6%) |
| Dec 2012 | $3.07B(+29.9%) | $1.00B(+29.2%) | $3.07B(+13.5%) |
| Sep 2012 | - | $776.63M(-13.4%) | $2.70B(+9.0%) |
| Jun 2012 | - | $897.21M(+129.8%) | $2.48B(+11.9%) |
| Mar 2012 | - | $390.49M(-38.9%) | $2.22B(-6.2%) |
| Dec 2011 | $2.36B(+6.7%) | $639.44M(+15.6%) | $2.36B(-4.3%) |
| Sep 2011 | - | $553.26M(-12.5%) | $2.47B(+6.8%) |
| Jun 2011 | - | $632.62M(+17.8%) | $2.31B(+0.4%) |
| Mar 2011 | - | $536.88M(-28.1%) | $2.30B(+4.0%) |
| Dec 2010 | $2.21B(-18.7%) | $746.35M(+88.4%) | $2.21B(-10.1%) |
| Sep 2010 | - | $396.17M(-36.5%) | $2.46B(-4.2%) |
| Jun 2010 | - | $623.55M(+39.2%) | $2.57B(+5.7%) |
| Mar 2010 | - | $447.96M(-55.0%) | $2.43B(+3.4%) |
| Dec 2009 | $2.72B(+17.5%) | $996.28M(+97.9%) | $2.35B(+15.7%) |
| Sep 2009 | - | $503.55M(+3.9%) | $2.03B(+1.4%) |
| Jun 2009 | - | $484.69M(+31.7%) | $2.00B(-3.8%) |
| Mar 2009 | - | $368.02M(-45.6%) | $2.08B(-1.1%) |
| Dec 2008 | $2.32B(-26.1%) | $676.71M(+42.5%) | $2.11B(+47.3%) |
| Sep 2008 | - | $474.82M(-15.7%) | $1.43B(-11.2%) |
| Jun 2008 | - | $563.10M(+43.9%) | $1.61B(-3.2%) |
| Mar 2008 | - | $391.37M(-40.3%) | $1.66B(-7.4%) |
| Dec 2007 | $3.13B(+40.5%) | - | - |
| Sep 2007 | - | $655.49M(+6.4%) | $1.79B(+11.4%) |
| Jun 2007 | - | $615.77M(+17.6%) | $1.61B(+21.1%) |
| Mar 2007 | - | $523.74M(+11.1%) | $1.33B(-13.0%) |
| Dec 2006 | $2.23B(+47.2%) | - | - |
| Sep 2006 | - | $471.47M(+40.8%) | $1.53B(+14.3%) |
| Jun 2006 | - | $334.75M(+10.8%) | $1.34B(+5.5%) |
| Mar 2006 | - | $302.15M(-28.0%) | $1.27B(+6.2%) |
| Dec 2005 | $1.51B(+5.1%) | $419.86M(+49.9%) | $1.19B(+3.9%) |
| Sep 2005 | - | $280.13M(+5.7%) | $1.15B(-1.9%) |
| Jun 2005 | - | $264.98M(+16.0%) | $1.17B(-4.1%) |
| Mar 2005 | - | $228.35M(-39.1%) | $1.22B(-3.3%) |
| Dec 2004 | $1.44B(-5.9%) | $374.65M(+24.0%) | $1.26B(+42.2%) |
| Sep 2004 | - | $302.18M(-3.9%) | $887.18M(+51.7%) |
| Jun 2004 | - | $314.49M(+16.3%) | $585.00M(+116.3%) |
| Mar 2004 | - | $270.51M(-0.2%) | $270.51M(-0.2%) |
| Dec 2003 | $1.53B(+32.4%) | - | - |
| Dec 2002 | $1.16B(-78.1%) | $271.12M | $271.12M |
| Dec 2001 | $5.27B(+97.9%) | - | - |
| Dec 2000 | $2.66B(+100.0%) | - | - |
| Dec 1999 | $1.33B(-0.2%) | - | - |
| Dec 1998 | $1.34B(-35.0%) | - | - |
| Dec 1997 | $2.05B(+34.0%) | - | - |
| Dec 1996 | $1.53B(-25.8%) | - | - |
| Dec 1995 | $2.06B(-7.4%) | - | - |
| Dec 1994 | $2.23B(+7.7%) | - | - |
| Dec 1993 | $2.07B | - | - |
FAQ
- What is Novartis AG annual capital expenditures?
- What is the all-time high annual CAPEX for Novartis AG?
- What is Novartis AG annual CAPEX year-on-year change?
- What is Novartis AG quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Novartis AG?
- What is Novartis AG quarterly CAPEX year-on-year change?
- What is Novartis AG TTM capital expenditures?
- What is the all-time high TTM CAPEX for Novartis AG?
- What is Novartis AG TTM CAPEX year-on-year change?
What is Novartis AG annual capital expenditures?
The current annual CAPEX of NVS is $3.81B
What is the all-time high annual CAPEX for Novartis AG?
Novartis AG all-time high annual capital expenditures is $5.27B
What is Novartis AG annual CAPEX year-on-year change?
Over the past year, NVS annual capital expenditures has changed by +$1.06B (+38.46%)
What is Novartis AG quarterly capital expenditures?
The current quarterly CAPEX of NVS is $829.52M
What is the all-time high quarterly CAPEX for Novartis AG?
Novartis AG all-time high quarterly capital expenditures is $1.89B
What is Novartis AG quarterly CAPEX year-on-year change?
Over the past year, NVS quarterly capital expenditures has changed by +$30.52M (+3.82%)
What is Novartis AG TTM capital expenditures?
The current TTM CAPEX of NVS is $4.03B
What is the all-time high TTM CAPEX for Novartis AG?
Novartis AG all-time high TTM capital expenditures is $4.25B
What is Novartis AG TTM CAPEX year-on-year change?
Over the past year, NVS TTM capital expenditures has changed by +$567.51M (+16.37%)